• Home
  • Journal
  • Public Companies
  • LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results

LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results

Written by Customer Service on . Posted in Public Companies.

BURLINGTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q1 2020 preliminary, unaudited results and withdrew prior annual guidance for 2020 due to the potential impact of COVID-19.Q1 2020 Preliminary Results
Sales of $30.4mm to $30.6mmOperating income of $4.2mm to $4.4mmEarnings of $0.15 to $0.16 per diluted shareCash balance of $30.6mm and no long-term debt at March 31, 2020The COVID-19 pandemic began to negatively impact sales in the second half of March.  Due to the unpredictable magnitude and duration of the COVID-19 pandemic, the Company is withdrawing its previously announced annual guidance for 2020.The Company will release its first quarter 2020 financial results, as well as additional information related to the impact of the COVID-19 pandemic, on Thursday, April 30, 2020, after the market close.  The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results.Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 3349306. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.About LeMaitre VascularLeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc. For more information about the Company, please visit http://www.lemaitre.com.CONTACT: J.J. Pellegrino, CFO
LeMaitre Vascular
781-425-1691

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.